As of Mar 03
| +0.04 / +2.21%|
The 6 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +251.35% increase from the last price of 1.85.
The current consensus among 7 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.